pubmed-article:16644716 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0043157 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0337810 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0028754 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0085295 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0021655 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0205419 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
pubmed-article:16644716 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
pubmed-article:16644716 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16644716 | pubmed:dateCreated | 2006-4-28 | lld:pubmed |
pubmed-article:16644716 | pubmed:abstractText | Interleukin (IL)-10 is a major anti-inflammatory cytokine that has been associated with obesity and type 2 diabetes. The three polymorphisms -1082G/A, -819C/T, and -592C/A in the IL10 promoter were reported to influence IL10 transcription. We investigated whether these polymorphisms were associated with type 2 diabetes and related traits in a cohort of Italian Caucasians comprising 551 type 2 diabetic and 1,131 control subjects. The -819C/T and -592C/A polymorphisms were in perfect linkage disequilibrium (r(2) = 1.0). The -1082G/A polymorphism was not associated with type 2 diabetes or related traits. Although the -592C/A polymorphism was not associated with type 2 diabetes, nondiabetic homozygous carriers of the A allele showed increased BMI and insulin resistance and lower plasma IL-10 levels compared with the other genotypes. In the nondiabetic group, the ATA haplotype was associated with an increased risk for obesity (odds ratio 1.28 [95% CI 1.02-1.60]; P = 0.02). The ATA/ATA composite genotype was associated with an increased risk for obesity (1.96 [1.16-3.31]; P = 0.01) and insulin resistance (1.99 [1.12-3.53]; P = 0.01). This study suggests that polymorphisms and haplotypes of the IL10 promoter may be associated with obesity and insulin resistance in a large sample of Italian Caucasians. | lld:pubmed |
pubmed-article:16644716 | pubmed:language | eng | lld:pubmed |
pubmed-article:16644716 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16644716 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16644716 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16644716 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16644716 | pubmed:month | May | lld:pubmed |
pubmed-article:16644716 | pubmed:issn | 0012-1797 | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:TassiVittorio... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:PerticoneFran... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:HribalMarta... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:LauroRenatoR | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:SestiGiorgioG | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:ScarpelliDani... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:MariniMaria... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:CardelliniMar... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:AndreozziFran... | lld:pubmed |
pubmed-article:16644716 | pubmed:author | pubmed-author:LarattaEmanue... | lld:pubmed |
pubmed-article:16644716 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16644716 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:16644716 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16644716 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16644716 | pubmed:pagination | 1529-33 | lld:pubmed |
pubmed-article:16644716 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:meshHeading | pubmed-meshheading:16644716... | lld:pubmed |
pubmed-article:16644716 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16644716 | pubmed:articleTitle | Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. | lld:pubmed |
pubmed-article:16644716 | pubmed:affiliation | Dipartimento di Medicina Sperimentale e Clinica, Policlinico Mater Domini, University Magna Graecia of Catanzaro, Via Tommaso Campanella, 88100 Catanzaro, Italy. | lld:pubmed |
pubmed-article:16644716 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16644716 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16644716 | pubmed:publicationType | Multicenter Study | lld:pubmed |
entrez-gene:3586 | entrezgene:pubmed | pubmed-article:16644716 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16644716 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16644716 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16644716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16644716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16644716 | lld:pubmed |